RecruitingNCT07335341

Case-Specific Health Care Professional Clinical Survey of Liberant™ Thrombectomy System


Sponsor

Medtronic Endovascular

Enrollment

50 participants

Start Date

Feb 24, 2026

Study Type

OBSERVATIONAL

Conditions

Summary

The purpose of Case-Specific Health Care Professional (HCP) Clinical Survey of Liberant™ Thrombectomy System, also known as the Liberant Clinical Assessment, is to collect first-in-human clinical data to confirm the safety and performance of the Medtronic Liberant™ thrombectomy system when used for the removal of fresh, soft emboli or thrombi from the vessels of the peripheral arterial and venous systems


Eligibility

Min Age: 22 Years

Inclusion Criteria3

  • Patient case selection to be included in the clinical assessment will be specific to Liberant and will be made according to the following criteria:
  • Patient treated is age ≥ 22 years at the time of procedure
  • Use of Liberant in accordance with the device labeling within 72 hours of index procedure

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICELiberant Thrombectomy System

The Liberant thrombectomy system is indicated for the removal of fresh, soft emboli or thrombi from the vessels of the peripheral arterial and venous systems


Locations(1)

Naples Comprehensive Health

Naples, Florida, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07335341


Related Trials